Patrick Lamy

Patrick Lamy is a declared insider of Akero Therapeutics, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 8 December 2023 to 9 December 2025, the count stands at 17 filings.

Every open-market trade on record is a sale: 5 sales worth €213k. Outside the open market, there are 5 share grants and 5 option exercises. In 2025 alone, the filings show no purchases and 3 sales.

On 9 December 2025 came the latest disclosure, a transaction in Akero Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.